Emerging Therapies Plaque Psoriasis

C-Jun Protein Linked to Psoriasis
June 22, 2021

The pro-inflammatory transcription factor is critical for the expression of IL-23, which is known to play a role in psoriasis.

Voltaire-X Phase 3 Data for Chronic Plaque Psoriasis Support Interchangeability Application
April 26, 2021

Voltaire-X study data shows that switching several times between Cyltezo and Humira results in similar pharmacokinetics, efficacy, immunogenicity, and safety in people with moderate to severe chronic plaque psoriasis.

Biologic Therapy for Psoriasis May Reduce Heart Disease
April 06, 2021

A study found psoriasis patients treated with biologic therapy had a significant reduction in high-risk plaque in heart arteries over 1 year.